PMID- 30624974 OWN - NLM STAT- MEDLINE DCOM- 20191119 LR - 20210811 IS - 1522-1490 (Electronic) IS - 0363-6119 (Print) IS - 0363-6119 (Linking) VI - 316 IP - 2 DP - 2019 Feb 1 TI - AT(1) receptors in the subfornical organ modulate arterial pressure and the baroreflex in two-kidney, one-clip hypertensive rats. PG - R172-R185 LID - 10.1152/ajpregu.00289.2018 [doi] AB - The subfornical organ (SFO), a forebrain circumventricular organ that lies outside the blood-brain barrier, has been implicated in arterial pressure and baroreflex responses to angiotensin II (ANG II). We tested whether pharmacological inhibition or selective silencing of SFO ANG II type 1 receptors (AT(1)R) of two-kidney, one-clip rats with elevated plasma ANG II decreases resting arterial pressure and renal sympathetic nerve activity (RSNA) and/or modulates arterial baroreflex responses of heart rate (HR) and RSNA. Male Sprague-Dawley rats underwent renal artery clipping [2-kidney, 1-clip (2K,1C)] or sham clipping (sham). After 6 wk, conscious rats instrumented with vascular catheters, renal nerve electrodes, and a cannula directed to the SFO were studied. In another set of experiments, rats were instrumented with hemodynamic and nerve radio transmitters and injected with scrambled RNA or silencing RNA targeted against AT(1)R. Mean arterial pressure (MAP) was significantly higher in 2K,1C rats. Acute SFO injection with the AT(1)R inhibitor losartan did not change MAP in sham or 2K,1C rats. Baroreflex curves of HR and RSNA were shifted rightward in 2K,1C rats. Losartan exerted no effect. SFO AT(1)R knockdown did not influence MAP in sham rats but decreased MAP in 2K,1C rats, despite no change in plasma ANG II or resting RSNA. AT(1)R knockdown prevented the reduction in maximum gain and slope of baroreflex responses of HR and RSNA; the reduced RSNA response to baroreceptor unloading was partially restored in 2K,1C rats. These findings show that AT(1)R activation within the SFO contributes to hypertension and baroreflex dysfunction in 2K,1C rats and highlight the temporal requirement for reversal of these effects. FAU - Rossi, Noreen F AU - Rossi NF AUID- ORCID: 0000-0002-5886-427X AD - Departments of Internal Medicine and Physiology, Wayne State University School of Medicine , Detroit, Michigan. AD - John D. Dingell Veterans Administration Medical Center , Detroit, Michigan. FAU - Zenner, Zachary AU - Zenner Z AD - Departments of Internal Medicine and Physiology, Wayne State University School of Medicine , Detroit, Michigan. FAU - Rishi, Arun K AU - Rishi AK AD - Department of Oncology, Wayne State University School of Medicine , Detroit, Michigan. AD - John D. Dingell Veterans Administration Medical Center , Detroit, Michigan. FAU - Levi, Edi AU - Levi E AD - Department of Pathology, Wayne State University School of Medicine , Detroit, Michigan. AD - John D. Dingell Veterans Administration Medical Center , Detroit, Michigan. FAU - Maliszewska-Scislo, Maria AU - Maliszewska-Scislo M AD - Departments of Internal Medicine and Physiology, Wayne State University School of Medicine , Detroit, Michigan. LA - eng GR - I01 BX001164/BX/BLRD VA/United States GR - I01 RX000851/RX/RRD VA/United States GR - IK6 BX004015/BX/BLRD VA/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20190109 PL - United States TA - Am J Physiol Regul Integr Comp Physiol JT - American journal of physiology. Regulatory, integrative and comparative physiology JID - 100901230 RN - 0 (Receptor, Angiotensin, Type 1) RN - 11128-99-7 (Angiotensin II) RN - JMS50MPO89 (Losartan) SB - IM MH - Angiotensin II/pharmacology MH - Animals MH - Arterial Pressure/*drug effects MH - Baroreflex/*drug effects MH - Blood Pressure/physiology MH - Hemodynamics/drug effects MH - Hypertension/physiopathology MH - Losartan/*pharmacology MH - Male MH - Rats, Sprague-Dawley MH - Receptor, Angiotensin, Type 1/*drug effects MH - Renal Artery/physiopathology MH - Subfornical Organ/*drug effects MH - Surgical Instruments PMC - PMC6397354 OTO - NOTNLM OT - Goldblatt kidney OT - angiotensin II OT - renal sympathetic nerve activity COIS- No conflicts of interest, financial or otherwise, are declared by the authors. EDAT- 2019/01/10 06:00 MHDA- 2019/11/20 06:00 PMCR- 2020/02/01 CRDT- 2019/01/10 06:00 PHST- 2019/01/10 06:00 [pubmed] PHST- 2019/11/20 06:00 [medline] PHST- 2019/01/10 06:00 [entrez] PHST- 2020/02/01 00:00 [pmc-release] AID - R-00289-2018 [pii] AID - 10.1152/ajpregu.00289.2018 [doi] PST - ppublish SO - Am J Physiol Regul Integr Comp Physiol. 2019 Feb 1;316(2):R172-R185. doi: 10.1152/ajpregu.00289.2018. Epub 2019 Jan 9.